Markets›Health care›LLY

Eli Lilly

LLY
1,183.46
+1.57 (+0.13%)
Closing price for Sep 25, 2026 from Polygon.io

Valuation

Market value1.11T
Enterprise value1.16T
Price to earnings (P/E)39.7
Price to sales14.0
Price to book32.9

Profitability (last 12 months)

Revenue79.67B
Net income26.71B
Gross margin83.4%
Net margin33.5%
Return on equity78.8%
Return on assets18.8%

Growth (last fiscal year, FY 2025)

Revenue growth+44.7%
EPS growth+96.0%

Balance sheet (latest quarter)

Cash and equivalents8.95B
Total debt54.91B
Debt to equity1.62
Current ratio1.35

Per share and dividends

EPS, diluted (last 12 months)29.80
Shares outstanding941.36M
Dividends paid (last 12 months)None

Trading

Price1,183.46
52-week high1,292.65
52-week low716.08
1-year price change+62.90%
Average volume (3 months)2.57M
Beta against the S&P 500 (1 year)0.31

Calculated from Eli Lilly's SEC filings (latest quarter ending Jun 30, 2026) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.